Read More Pharma Industry News Laurus Labs acquires stake in Indian CAR-T therapy developer ImmunoACT Laurus Labs said that it has acquired a stake of 26.62% in Immunoadoptive Cell Therapy Private Limited (ImmunoACT),… bySrinathNovember 21, 2021
